Disitamab vedotin
CAS No. 2136633-23-1
Disitamab vedotin ( —— )
产品货号. M35132 CAS No. 2136633-23-1
Disitamab vedotin (RC48) 是一种抗体-活性分子偶联物 (ADC),包含抗人表皮生长因子受体2 (HER2) 的单克隆抗体,该单克隆抗体通过可降解连接子结合到细胞毒性剂 MMAE。Disitamab vedotin 增强抗肿瘤免疫。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 2MG | ¥4483 | 有现货 |
|
| 5MG | ¥6767 | 有现货 |
|
| 10MG | ¥9367 | 有现货 |
|
| 25MG | ¥13450 | 有现货 |
|
| 50MG | ¥18142 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Disitamab vedotin
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述Disitamab vedotin (RC48) 是一种抗体-活性分子偶联物 (ADC),包含抗人表皮生长因子受体2 (HER2) 的单克隆抗体,该单克隆抗体通过可降解连接子结合到细胞毒性剂 MMAE。Disitamab vedotin 增强抗肿瘤免疫。
-
产品描述Disitamab vedotin (RC48) is an antibody-drug conjugate (ADC) comprising a monoclonal antibody against human epidermal growth factor receptor 2 (HER2) conjugated via a cleavable linker to the cytotoxic agent Monomethyl auristatin E (MMAE). Disitamab vedotin enhances antitumor immunity.
-
体外实验The antibody part was a humanized monoclonal antibody targeting HER2, the small molecule toxin was monomethyl auristatin E (MMAE), a synthetic antineoplastic agent. A protease cleavable linker covalently attached MMAE to the antibody.
-
体内实验——
-
同义词——
-
通路Others
-
靶点Other Targets
-
受体Antibody-Drug Conjugates (ADCs) | EGFR
-
研究领域——
-
适应症——
化学信息
-
CAS Number2136633-23-1
-
分子量Approximately 144.15 kDa
-
分子式——
-
纯度>98% (HPLC)
-
溶解度——
-
SMILES——
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Deeks ED. Disitamab Vedotin: First Approval. Drugs. 2021;81(16):1929-1935.?
产品手册
关联产品
-
Degarelix acetate(21...
Degarelix acetate is a competitive and reversible antagonist of gonadotropin-releasing hormone receptor (GnRHR) .
-
[D-Ala4]-Substance P...
[DAla4] Substance P (4-11) 是 Substance P (Substance P ) 的类似物,可抑制 125I-Bolton Hunter 偶联的 Eledoisin (IC50 为 0.5 μM) 和 125I-Bolton Hunter 偶联的 Substance P (IC50 为 0.15 μM) 与大鼠大脑皮层膜的结合。
-
Quercetin 3-O-robino...
The fruits of Azadirachta indica.
021-51111890
购物车()
sales@molnova.cn

